PMV Pharmaceuticals
PMVP
PMVP
55 hedge funds and large institutions have $36.8M invested in PMV Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
10% less capital invested
Capital invested by funds: $40.7M → $36.8M (-$3.92M)
35% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 20
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $8K
Holders
55
Holding in Top 10
2
Calls
–
Puts
$8K
Top Buyers
| 1 | +$1.33M | |
| 2 | +$257K | |
| 3 | +$229K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$157K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$47.4K |
Top Sellers
| 1 | -$3.6M | |
| 2 | -$320K | |
| 3 | -$292K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$142K |
| 5 |
Millennium Management
New York
|
-$139K |
